VALNEVA SE (VLA.PA) Financials
VLA.PA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 502.8 million | 313.6 million |
| 2023-12-31 | 469.4 million | 341.1 million |
| 2023-09-30 | 520.5 million | 363.0 million |
| 2023-06-30 | 542.6 million | 351.9 million |
VLA.PA Free Cash Flow and Stock based compensation
No data available :(
VLA.PA Net Income
No data available :(
VLA.PA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 176.6 million | - | - |
| 2023-12-31 | 126.1 million | - | 32.0 million |
| 2023-09-30 | 171.3 million | - | 53.6 million |
| 2023-06-30 | 204.4 million | - | 53.8 million |
VLA.PA Shares Outstanding
VLA.PA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 4.5 million | 13.1 million | 11.7 million | 11.3 million |
| 2023-12-31 | 5.9 million | 17.7 million | 12.7 million | 14.8 million |
| 2023-09-30 | 1.2 million | 16.2 million | 12.2 million | 13.9 million |
| 2023-06-30 | 3.4 million | 11.9 million | 12.9 million | 11.0 million |
VLA.PA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 32.8 million | 22.2 million |
| 2023-12-31 | 41.9 million | 26.1 million |
| 2023-09-30 | 38.1 million | 21.0 million |
| 2023-06-30 | 40.2 million | 33.4 million |
VLA.PA
Price: €4.03
52 week price:
Earnings Per Share: -0.19 EUR
P/E Ratio: -4.46
Exchange: PAR
Sector: Healthcare
Industry: Biotechnology
Volume: 278769
Market Capitalization: 566.6 million